Can a breastfeeding mother with a past medical history of pre-existing conditions and allergies take Akbroxl (generic name)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Safety of Akbroxl (Bromhexine) During Breastfeeding

Akbroxl (bromhexine) can be given to a breastfeeding mother, as mucolytic agents like bromhexine are generally considered compatible with breastfeeding when used for respiratory conditions. 1

Evidence-Based Rationale

Mucolytic Safety Profile

  • Bromhexine is a mucolytic agent used to facilitate mucus clearance in respiratory conditions, and routine therapy with mucolytics should continue during breastfeeding to maintain maternal stability. 2
  • The general principle for medications during lactation is that most drugs are compatible with breastfeeding, with only a limited number of agents contraindicated. 3

Key Pharmacologic Considerations

  • For a drug to pose risk to the breastfed infant, it must be transferred into breast milk AND absorbed from the infant's gastrointestinal tract in sufficient quantities. 2
  • Medications with poor oral bioavailability, high molecular weight, or strong protein binding are less likely to affect the nursing infant even if small amounts appear in breast milk. 2

Clinical Decision Framework

When prescribing any medication to a breastfeeding mother, consider:

  • Timing of doses: Schedule medication administration before the infant's longest sleep interval to minimize exposure. 4
  • Maternal benefit vs. infant risk: The benefits of maintaining maternal respiratory health generally outweigh theoretical risks of medication exposure through breast milk. 3
  • Infant monitoring: Monitor the infant for unusual symptoms or changes in feeding patterns when any medication is used. 3

Important Caveats

  • Premature or compromised infants may require special consideration due to altered drug metabolism and potential for accumulation. 5
  • Consult LactMed database (government-sponsored, authoritative resource) for the most current safety information on specific medications during breastfeeding. 3, 4
  • Topical or inhaled formulations are preferred when available, as they result in minimal systemic absorption and lower infant exposure. 4, 5

Comparative Context

For respiratory conditions during breastfeeding:

  • Inhaled bronchodilators, corticosteroids, and mucolytics should continue to maintain maternal stability. 2
  • Most respiratory medications used during pregnancy can safely continue during lactation. 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Sitagliptin Safety During Breastfeeding

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Medication Safety in Breastfeeding.

American family physician, 2022

Research

Medications in the breast-feeding mother.

American family physician, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.